Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02935907
Title APG-115 in Patients With Advanced Solid Tumors or Lymphomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ascentage Pharma Group Inc.
Indications

lymphoma

Advanced Solid Tumor

Therapies

APG-115

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.